Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

18 May 2023 10:23

RNS Number : 8917Z
Mandarin Oriental International Ltd
18 May 2023
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

18th May 2023 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2023.

 

The Group recorded an underlying profit in the first quarter of 2023, driven by improved performance from both the Group's owned hotels and its management business. RevPAR grew substantially in Asia compared to last year, as the region benefitted from the removal of travel restrictions. As a result, the Group's owned hotels saw a significantly improved performance, particularly in Hong Kong, Tokyo, and Bangkok. In the rest of the world, our hotels were also able to achieve a higher RevPAR compared to both last year and 2019, driven by strong rates.

 

The first quarter saw progress on a number of hotel developments. In January, the Group announced a new management contract for a luxury beach resort in Mallorca, Spain, scheduled to open by the end of 2024. In February, after three years' work, the Emirates Palace hotel in Abu Dhabi was rebranded as Emirates Palace Mandarin Oriental, Abu Dhabi. In March, Mandarin Oriental, Singapore, closed for a substantial renovation; it is expected to reopen in September 2023.

 

As a result of improved trading conditions, the Group generated underlying earnings before interest, tax, depreciation, and amortisation ('EBITDA') of US$30 million, a substantial increase from the EBITDA loss of US$1 million in the first quarter of 2022. Owned hotels reported an EBITDA of US$19 million, with almost all hotels delivering increased financial performance. The management business saw significant growth and generated higher fees, with hotels, particularly in Hong Kong and Mainland China, contributing to an EBITDA of US$7 million. Unaudited underlying profit in the first quarter was US$3 million, much improved from an underlying loss of US$26 million in 2022.

 

The Group's redevelopment project in Causeway Bay, Hong Kong, formerly the site of The Excelsior hotel, is ongoing, in line with our budget, and is expected to complete in early 2025.

 

Consolidated net debt as at 31st March 2023 reduced to US$311 million (US$376 million at 31st December 2022). The Group's liquidity position remains robust, with US$453 million in available committed debt facilities and US$306 million of cash reserves. Gearing was 6% of adjusted shareholders' funds.

 

On 2nd May 2023, the Company announced that Laurent Kleitman would replace James Riley as Group Chief Executive of Mandarin Oriental International Limited with effect from 1st September 2023.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

 

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKVLBFXELLBBB
Date   Source Headline
6th May 20093:17 pmRNSDoc re. non-routine AGM resolutions
6th May 20092:57 pmRNSResult of AGM
6th May 200912:14 pmRNSInterim Management Statement
29th Apr 200911:36 amRNSDividend
24th Apr 200911:38 amRNSDirector/PDMR Shareholding
23rd Apr 200911:12 amRNSDirector/PDMR Shareholding
20th Apr 200911:07 amRNSAnnual Information Update
9th Apr 200910:11 amRNSAnnual Financial Report
24th Mar 20098:54 amRNSAdditional Listing
19th Mar 20099:58 amRNSDirector/PDMR Shareholding
5th Mar 20099:05 amRNSFinal Results
9th Feb 20099:24 amRNSNotice of 2008 Final Results
20th Jan 20099:11 amRNSMO To Sell Its Equity Investment in Macau Hotel
2nd Jan 200910:26 amRNSDirector/PDMR Shareholding
29th Dec 200810:09 amRNSDirector/PDMR Shareholding
13th Nov 20089:09 amRNSInterim Management Statement
3rd Nov 20089:09 amRNSTotal Voting Rights
16th Oct 200811:26 amRNSIssue of Equity
15th Oct 200811:52 amRNSDividend
2nd Oct 200811:42 amRNSDividend
30th Sep 200811:51 amRNSTotal Voting Rights
29th Sep 200811:09 amRNSIssue of Equity
31st Jul 200810:05 amRNSInterim Results
4th Jul 200810:24 amRNSNotice of 2008 Half-Yearly Re
30th Jun 200810:22 amRNSTotal Voting Rights
19th Jun 200811:37 amRNSDirector Declaration
10th Jun 200810:22 amRNSIssue of Equity
4th Jun 200811:14 amRNSBermuda Takeover Code
3rd Jun 200811:26 amRNSDirector/PDMR Shareholding
29th May 200811:36 amRNSDirector/PDMR Shareholding
28th May 200811:16 amRNSDirector/PDMR Shareholding
27th May 200811:52 amRNSDirector/PDMR Shareholding
23rd May 200811:24 amRNSDirector/PDMR Shareholding
21st May 200812:40 pmRNSDirector/PDMR Shareholding
7th May 20083:26 pmRNSAGM Statement
7th May 20082:51 pmRNSResult of AGM
7th May 200812:31 pmRNSInterim Management Statement
2nd May 200810:23 amRNSAnnual Information Update
30th Apr 200810:21 amRNSDividend
11th Apr 200810:26 amRNSAnnual Report & Notice of AGM
9th Apr 200811:23 amRNSDirector/PDMR Shareholding
8th Apr 200811:49 amRNSDirector/PDMR Shareholding
2nd Apr 200811:29 amRNSDirector/PDMR Shareholding
1st Apr 200812:03 pmRNSDirector/PDMR Shareholding
18th Mar 200812:50 pmRNSDirector/PDMR Shareholding
18th Mar 200811:25 amRNSDirector/PDMR Shareholding
12th Mar 200811:18 amRNSDirector/PDMR Shareholding
10th Mar 200811:04 amRNSDirector/PDMR Shareholding
10th Mar 200811:04 amRNSDirector Declaration
7th Mar 200812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.